Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1529248

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1529248

LAMEA Postpartum Depression Drugs Market Size, Share & Trends Analysis Report By Treatment (Pharmacotherapy, Hormonal Therapy, and Others), By Route of Administration, By Distribution Channel, By Type, By Country and Growth Forecast, 2024 - 2031

PUBLISHED:
PAGES: 142 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Multi User License)
USD 1800
PDF (Corporate User License)
USD 2520

Add to Cart

The Latin America, Middle East and Africa Postpartum Depression Drugs Market would witness market growth of 11.2% CAGR during the forecast period (2024-2031).

The Brazil market dominated the LAMEA Postpartum Depression Drugs Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $31.7 million by 2031. The Argentina market is showcasing a CAGR of 12.4% during (2024 - 2031). Additionally, The UAE market would register a CAGR of 10.9% during (2024 - 2031).

Adoption rates are influenced by screening practices for postpartum depression during prenatal and postnatal visits. Effective screening tools, such as the Edinburgh Postnatal Depression Scale (EPDS), help identify women at risk or experiencing symptoms, facilitating timely interventions, including pharmacological treatments. Adoption also depends on prescribing practices among healthcare providers. General practitioners, obstetricians, gynecologists, and psychiatrists may have varying comfort levels and expertise in prescribing antidepressants for postpartum depression.

Patient acceptance of these drugs is crucial for adoption. Factors influencing acceptance include perceived stigma associated with mental health disorders, concerns about medication safety during breastfeeding, and cultural beliefs about treatment preferences (e.g., preference for non-pharmacological approaches). Adoption rates are influenced by access to healthcare services, including the availability of mental health specialists, affordability of medications, and accessibility of follow-up care. Inadequate access to healthcare can hinder adoption as women may face barriers to receiving timely diagnoses and accessing pharmacological treatments.

Improved Drug Accessibility: With increased healthcare expenditure, there are more resources available for subsidizing medications and expanding healthcare coverage. This means that these drugs become more accessible to a broader segment of the population, including those who might have previously faced financial barriers. Increased funding typically improves healthcare infrastructure, leading to better diagnostic and treatment services for postpartum depression. More specialized clinics and healthcare providers can focus on maternal mental health, improving both diagnosis and treatment efficacy. As a result, the rising healthcare sector in LAMEA will fuel the demand for postpartum depression drugs in the upcoming years.

Based on Treatment, the market is segmented into Pharmacotherapy, Hormonal Therapy, and Others. Based on Route of Administration, the market is segmented into Oral, Parenteral, and Others. Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy. Based on Type, the market is segmented into Postpartum Anxiety, Postpartum Blues, Postpartum Obsessive-Compulsive Disorder (OCD), Postpartum Panic Disorder, Postpartum Post-Traumatic Stress Disorder (PTSD), and Postpartum Psychosis. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

List of Key Companies Profiled

  • Pfizer, Inc.
  • Eli Lilly And Company
  • Novartis AG
  • GlaxoSmithKline PLC (GSK)
  • Merck & Co., Inc.
  • Biogen, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Bausch Health Companies, Inc. (DermTech, Inc.)
  • Cipla Limited
  • Sage Therapeutics, Inc.

LAMEA Postpartum Depression Drugs Market Report Segmentation

By Treatment

  • Pharmacotherapy
  • Hormonal Therapy
  • Others

By Route of Administration

  • Oral
  • Parenteral
  • Others

By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

By Type

  • Postpartum Anxiety
  • Postpartum Blues
  • Postpartum Obsessive-Compulsive Disorder (OCD)
  • Postpartum Panic Disorder
  • Postpartum Post-Traumatic Stress Disorder (PTSD)
  • Postpartum Psychosis

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 LAMEA Postpartum Depression Drugs Market, by Treatment
    • 1.4.2 LAMEA Postpartum Depression Drugs Market, by Route of Administration
    • 1.4.3 LAMEA Postpartum Depression Drugs Market, by Distribution Channel
    • 1.4.4 LAMEA Postpartum Depression Drugs Market, by Type
    • 1.4.5 LAMEA Postpartum Depression Drugs Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market at a Glance

  • 2.1 Key Highlights

Chapter 3. Market Overview

  • 3.1 Introduction
    • 3.1.1 Overview
      • 3.1.1.1 Market Composition and Scenario
  • 3.2 Key Factors Impacting the Market
    • 3.2.1 Market Drivers
    • 3.2.2 Market Restraints
    • 3.2.3 Market Opportunities
    • 3.2.4 Market Challenges
  • 3.3 Porter Five Forces Analysis

Chapter 4. LAMEA Postpartum Depression Drugs Market by Treatment

  • 4.1 LAMEA Pharmacotherapy Market by Country
  • 4.2 LAMEA Hormonal Therapy Market by Country
  • 4.3 LAMEA Others Market by Country

Chapter 5. LAMEA Postpartum Depression Drugs Market by Route of Administration

  • 5.1 LAMEA Oral Market by Country
  • 5.2 LAMEA Parenteral Market by Country
  • 5.3 LAMEA Others Market by Country

Chapter 6. LAMEA Postpartum Depression Drugs Market by Distribution Channel

  • 6.1 LAMEA Hospital Pharmacy Market by Country
  • 6.2 LAMEA Retail Pharmacy Market by Country
  • 6.3 LAMEA Online Pharmacy Market by Country

Chapter 7. LAMEA Postpartum Depression Drugs Market by Type

  • 7.1 LAMEA Postpartum Anxiety Market by Country
  • 7.2 LAMEA Postpartum Blues Market by Country
  • 7.3 LAMEA Postpartum Obsessive-Compulsive Disorder (OCD) Market by Country
  • 7.4 LAMEA Postpartum Panic Disorder Market by Country
  • 7.5 LAMEA Postpartum Post-Traumatic Stress Disorder (PTSD) Market by Country
  • 7.6 LAMEA Postpartum Psychosis Market by Country

Chapter 8. LAMEA Postpartum Depression Drugs Market by Country

  • 8.1 Brazil Postpartum Depression Drugs Market
    • 8.1.1 Brazil Postpartum Depression Drugs Market by Treatment
    • 8.1.2 Brazil Postpartum Depression Drugs Market by Route of Administration
    • 8.1.3 Brazil Postpartum Depression Drugs Market by Distribution Channel
    • 8.1.4 Brazil Postpartum Depression Drugs Market by Type
  • 8.2 Argentina Postpartum Depression Drugs Market
    • 8.2.1 Argentina Postpartum Depression Drugs Market by Treatment
    • 8.2.2 Argentina Postpartum Depression Drugs Market by Route of Administration
    • 8.2.3 Argentina Postpartum Depression Drugs Market by Distribution Channel
    • 8.2.4 Argentina Postpartum Depression Drugs Market by Type
  • 8.3 UAE Postpartum Depression Drugs Market
    • 8.3.1 UAE Postpartum Depression Drugs Market by Treatment
    • 8.3.2 UAE Postpartum Depression Drugs Market by Route of Administration
    • 8.3.3 UAE Postpartum Depression Drugs Market by Distribution Channel
    • 8.3.4 UAE Postpartum Depression Drugs Market by Type
  • 8.4 Saudi Arabia Postpartum Depression Drugs Market
    • 8.4.1 Saudi Arabia Postpartum Depression Drugs Market by Treatment
    • 8.4.2 Saudi Arabia Postpartum Depression Drugs Market by Route of Administration
    • 8.4.3 Saudi Arabia Postpartum Depression Drugs Market by Distribution Channel
    • 8.4.4 Saudi Arabia Postpartum Depression Drugs Market by Type
  • 8.5 South Africa Postpartum Depression Drugs Market
    • 8.5.1 South Africa Postpartum Depression Drugs Market by Treatment
    • 8.5.2 South Africa Postpartum Depression Drugs Market by Route of Administration
    • 8.5.3 South Africa Postpartum Depression Drugs Market by Distribution Channel
    • 8.5.4 South Africa Postpartum Depression Drugs Market by Type
  • 8.6 Nigeria Postpartum Depression Drugs Market
    • 8.6.1 Nigeria Postpartum Depression Drugs Market by Treatment
    • 8.6.2 Nigeria Postpartum Depression Drugs Market by Route of Administration
    • 8.6.3 Nigeria Postpartum Depression Drugs Market by Distribution Channel
    • 8.6.4 Nigeria Postpartum Depression Drugs Market by Type
  • 8.7 Rest of LAMEA Postpartum Depression Drugs Market
    • 8.7.1 Rest of LAMEA Postpartum Depression Drugs Market by Treatment
    • 8.7.2 Rest of LAMEA Postpartum Depression Drugs Market by Route of Administration
    • 8.7.3 Rest of LAMEA Postpartum Depression Drugs Market by Distribution Channel
    • 8.7.4 Rest of LAMEA Postpartum Depression Drugs Market by Type

Chapter 9. Company Profiles

  • 9.1 Pfizer, Inc.
    • 9.1.1 Company Overview
    • 9.1.2 Financial Analysis
    • 9.1.3 Regional & Segmental Analysis
    • 9.1.4 Research & Development Expense
    • 9.1.5 SWOT Analysis
  • 9.2 Eli Lilly And Company
    • 9.2.1 Company Overview
    • 9.2.2 Financial Analysis
    • 9.2.3 Regional Analysis
    • 9.2.4 Research & Development Expenses
    • 9.2.5 SWOT Analysis
  • 9.3 Novartis AG
    • 9.3.1 Company Overview
    • 9.3.2 Financial Analysis
    • 9.3.3 Segmental and Regional Analysis
    • 9.3.4 Research & Development Expense
    • 9.3.5 SWOT Analysis
  • 9.4 GlaxoSmithKline PLC (GSK)
    • 9.4.1 Company Overview
    • 9.4.2 Financial Analysis
    • 9.4.3 Regional Analysis
    • 9.4.4 Research & Development Expense
    • 9.4.5 SWOT Analysis
  • 9.5 Merck & Co., Inc.
    • 9.5.1 Company Overview
    • 9.5.2 Financial Analysis
    • 9.5.3 Segmental and Regional Analysis
    • 9.5.4 Research & Development Expenses
    • 9.5.5 SWOT Analysis
  • 9.6 Biogen, Inc.
    • 9.6.1 Company Overview
    • 9.6.2 Financial Analysis
    • 9.6.3 Regional Analysis
    • 9.6.4 Research & Development Expense
    • 9.6.5 Recent strategies and developments:
      • 9.6.5.1 Trails and Approvals:
    • 9.6.6 SWOT Analysis
  • 9.7 Teva Pharmaceutical Industries Ltd.
    • 9.7.1 Company Overview
    • 9.7.2 Financial Analysis
    • 9.7.3 Regional Analysis
    • 9.7.4 Research & Development Expenses
    • 9.7.5 SWOT Analysis
  • 9.8 Bausch Health Companies, Inc. (DermTech, Inc.)
    • 9.8.1 Company Overview
    • 9.8.2 Financial Analysis
    • 9.8.3 Segmental and Regional Analysis
    • 9.8.4 Research & Development Expense
    • 9.8.5 SWOT Analysis
  • 9.9 Cipla Limited
    • 9.9.1 Company Overview
    • 9.9.2 Financial Analysis
    • 9.9.3 Segmental and Regional Analysis
    • 9.9.4 Research & Development Expense
    • 9.9.5 SWOT Analysis
  • 9.10. Sage Therapeutics, Inc.
    • 9.10.1 Company Overview
    • 9.10.2 Financial Analysis
    • 9.10.3 Research & Development Expenses

LIST OF TABLES

  • TABLE 1 LAMEA Postpartum Depression Drugs Market, 2020 - 2023, USD Million
  • TABLE 2 LAMEA Postpartum Depression Drugs Market, 2024 - 2031, USD Million
  • TABLE 3 LAMEA Postpartum Depression Drugs Market by Treatment, 2020 - 2023, USD Million
  • TABLE 4 LAMEA Postpartum Depression Drugs Market by Treatment, 2024 - 2031, USD Million
  • TABLE 5 LAMEA Pharmacotherapy Market by Country, 2020 - 2023, USD Million
  • TABLE 6 LAMEA Pharmacotherapy Market by Country, 2024 - 2031, USD Million
  • TABLE 7 LAMEA Hormonal Therapy Market by Country, 2020 - 2023, USD Million
  • TABLE 8 LAMEA Hormonal Therapy Market by Country, 2024 - 2031, USD Million
  • TABLE 9 LAMEA Others Market by Country, 2020 - 2023, USD Million
  • TABLE 10 LAMEA Others Market by Country, 2024 - 2031, USD Million
  • TABLE 11 LAMEA Postpartum Depression Drugs Market by Route of Administration, 2020 - 2023, USD Million
  • TABLE 12 LAMEA Postpartum Depression Drugs Market by Route of Administration, 2024 - 2031, USD Million
  • TABLE 13 LAMEA Oral Market by Country, 2020 - 2023, USD Million
  • TABLE 14 LAMEA Oral Market by Country, 2024 - 2031, USD Million
  • TABLE 15 LAMEA Parenteral Market by Country, 2020 - 2023, USD Million
  • TABLE 16 LAMEA Parenteral Market by Country, 2024 - 2031, USD Million
  • TABLE 17 LAMEA Others Market by Country, 2020 - 2023, USD Million
  • TABLE 18 LAMEA Others Market by Country, 2024 - 2031, USD Million
  • TABLE 19 LAMEA Postpartum Depression Drugs Market by Distribution Channel, 2020 - 2023, USD Million
  • TABLE 20 LAMEA Postpartum Depression Drugs Market by Distribution Channel, 2024 - 2031, USD Million
  • TABLE 21 LAMEA Hospital Pharmacy Market by Country, 2020 - 2023, USD Million
  • TABLE 22 LAMEA Hospital Pharmacy Market by Country, 2024 - 2031, USD Million
  • TABLE 23 LAMEA Retail Pharmacy Market by Country, 2020 - 2023, USD Million
  • TABLE 24 LAMEA Retail Pharmacy Market by Country, 2024 - 2031, USD Million
  • TABLE 25 LAMEA Online Pharmacy Market by Country, 2020 - 2023, USD Million
  • TABLE 26 LAMEA Online Pharmacy Market by Country, 2024 - 2031, USD Million
  • TABLE 27 LAMEA Postpartum Depression Drugs Market by Type, 2020 - 2023, USD Million
  • TABLE 28 LAMEA Postpartum Depression Drugs Market by Type, 2024 - 2031, USD Million
  • TABLE 29 LAMEA Postpartum Anxiety Market by Country, 2020 - 2023, USD Million
  • TABLE 30 LAMEA Postpartum Anxiety Market by Country, 2024 - 2031, USD Million
  • TABLE 31 LAMEA Postpartum Blues Market by Country, 2020 - 2023, USD Million
  • TABLE 32 LAMEA Postpartum Blues Market by Country, 2024 - 2031, USD Million
  • TABLE 33 LAMEA Postpartum Obsessive-Compulsive Disorder (OCD) Market by Country, 2020 - 2023, USD Million
  • TABLE 34 LAMEA Postpartum Obsessive-Compulsive Disorder (OCD) Market by Country, 2024 - 2031, USD Million
  • TABLE 35 LAMEA Postpartum Panic Disorder Market by Country, 2020 - 2023, USD Million
  • TABLE 36 LAMEA Postpartum Panic Disorder Market by Country, 2024 - 2031, USD Million
  • TABLE 37 LAMEA Postpartum Post-Traumatic Stress Disorder (PTSD) Market by Country, 2020 - 2023, USD Million
  • TABLE 38 LAMEA Postpartum Post-Traumatic Stress Disorder (PTSD) Market by Country, 2024 - 2031, USD Million
  • TABLE 39 LAMEA Postpartum Psychosis Market by Country, 2020 - 2023, USD Million
  • TABLE 40 LAMEA Postpartum Psychosis Market by Country, 2024 - 2031, USD Million
  • TABLE 41 LAMEA Postpartum Depression Drugs Market by Country, 2020 - 2023, USD Million
  • TABLE 42 LAMEA Postpartum Depression Drugs Market by Country, 2024 - 2031, USD Million
  • TABLE 43 Brazil Postpartum Depression Drugs Market, 2020 - 2023, USD Million
  • TABLE 44 Brazil Postpartum Depression Drugs Market, 2024 - 2031, USD Million
  • TABLE 45 Brazil Postpartum Depression Drugs Market by Treatment, 2020 - 2023, USD Million
  • TABLE 46 Brazil Postpartum Depression Drugs Market by Treatment, 2024 - 2031, USD Million
  • TABLE 47 Brazil Postpartum Depression Drugs Market by Route of Administration, 2020 - 2023, USD Million
  • TABLE 48 Brazil Postpartum Depression Drugs Market by Route of Administration, 2024 - 2031, USD Million
  • TABLE 49 Brazil Postpartum Depression Drugs Market by Distribution Channel, 2020 - 2023, USD Million
  • TABLE 50 Brazil Postpartum Depression Drugs Market by Distribution Channel, 2024 - 2031, USD Million
  • TABLE 51 Brazil Postpartum Depression Drugs Market by Type, 2020 - 2023, USD Million
  • TABLE 52 Brazil Postpartum Depression Drugs Market by Type, 2024 - 2031, USD Million
  • TABLE 53 Argentina Postpartum Depression Drugs Market, 2020 - 2023, USD Million
  • TABLE 54 Argentina Postpartum Depression Drugs Market, 2024 - 2031, USD Million
  • TABLE 55 Argentina Postpartum Depression Drugs Market by Treatment, 2020 - 2023, USD Million
  • TABLE 56 Argentina Postpartum Depression Drugs Market by Treatment, 2024 - 2031, USD Million
  • TABLE 57 Argentina Postpartum Depression Drugs Market by Route of Administration, 2020 - 2023, USD Million
  • TABLE 58 Argentina Postpartum Depression Drugs Market by Route of Administration, 2024 - 2031, USD Million
  • TABLE 59 Argentina Postpartum Depression Drugs Market by Distribution Channel, 2020 - 2023, USD Million
  • TABLE 60 Argentina Postpartum Depression Drugs Market by Distribution Channel, 2024 - 2031, USD Million
  • TABLE 61 Argentina Postpartum Depression Drugs Market by Type, 2020 - 2023, USD Million
  • TABLE 62 Argentina Postpartum Depression Drugs Market by Type, 2024 - 2031, USD Million
  • TABLE 63 UAE Postpartum Depression Drugs Market, 2020 - 2023, USD Million
  • TABLE 64 UAE Postpartum Depression Drugs Market, 2024 - 2031, USD Million
  • TABLE 65 UAE Postpartum Depression Drugs Market by Treatment, 2020 - 2023, USD Million
  • TABLE 66 UAE Postpartum Depression Drugs Market by Treatment, 2024 - 2031, USD Million
  • TABLE 67 UAE Postpartum Depression Drugs Market by Route of Administration, 2020 - 2023, USD Million
  • TABLE 68 UAE Postpartum Depression Drugs Market by Route of Administration, 2024 - 2031, USD Million
  • TABLE 69 UAE Postpartum Depression Drugs Market by Distribution Channel, 2020 - 2023, USD Million
  • TABLE 70 UAE Postpartum Depression Drugs Market by Distribution Channel, 2024 - 2031, USD Million
  • TABLE 71 UAE Postpartum Depression Drugs Market by Type, 2020 - 2023, USD Million
  • TABLE 72 UAE Postpartum Depression Drugs Market by Type, 2024 - 2031, USD Million
  • TABLE 73 Saudi Arabia Postpartum Depression Drugs Market, 2020 - 2023, USD Million
  • TABLE 74 Saudi Arabia Postpartum Depression Drugs Market, 2024 - 2031, USD Million
  • TABLE 75 Saudi Arabia Postpartum Depression Drugs Market by Treatment, 2020 - 2023, USD Million
  • TABLE 76 Saudi Arabia Postpartum Depression Drugs Market by Treatment, 2024 - 2031, USD Million
  • TABLE 77 Saudi Arabia Postpartum Depression Drugs Market by Route of Administration, 2020 - 2023, USD Million
  • TABLE 78 Saudi Arabia Postpartum Depression Drugs Market by Route of Administration, 2024 - 2031, USD Million
  • TABLE 79 Saudi Arabia Postpartum Depression Drugs Market by Distribution Channel, 2020 - 2023, USD Million
  • TABLE 80 Saudi Arabia Postpartum Depression Drugs Market by Distribution Channel, 2024 - 2031, USD Million
  • TABLE 81 Saudi Arabia Postpartum Depression Drugs Market by Type, 2020 - 2023, USD Million
  • TABLE 82 Saudi Arabia Postpartum Depression Drugs Market by Type, 2024 - 2031, USD Million
  • TABLE 83 South Africa Postpartum Depression Drugs Market, 2020 - 2023, USD Million
  • TABLE 84 South Africa Postpartum Depression Drugs Market, 2024 - 2031, USD Million
  • TABLE 85 South Africa Postpartum Depression Drugs Market by Treatment, 2020 - 2023, USD Million
  • TABLE 86 South Africa Postpartum Depression Drugs Market by Treatment, 2024 - 2031, USD Million
  • TABLE 87 South Africa Postpartum Depression Drugs Market by Route of Administration, 2020 - 2023, USD Million
  • TABLE 88 South Africa Postpartum Depression Drugs Market by Route of Administration, 2024 - 2031, USD Million
  • TABLE 89 South Africa Postpartum Depression Drugs Market by Distribution Channel, 2020 - 2023, USD Million
  • TABLE 90 South Africa Postpartum Depression Drugs Market by Distribution Channel, 2024 - 2031, USD Million
  • TABLE 91 South Africa Postpartum Depression Drugs Market by Type, 2020 - 2023, USD Million
  • TABLE 92 South Africa Postpartum Depression Drugs Market by Type, 2024 - 2031, USD Million
  • TABLE 93 Nigeria Postpartum Depression Drugs Market, 2020 - 2023, USD Million
  • TABLE 94 Nigeria Postpartum Depression Drugs Market, 2024 - 2031, USD Million
  • TABLE 95 Nigeria Postpartum Depression Drugs Market by Treatment, 2020 - 2023, USD Million
  • TABLE 96 Nigeria Postpartum Depression Drugs Market by Treatment, 2024 - 2031, USD Million
  • TABLE 97 Nigeria Postpartum Depression Drugs Market by Route of Administration, 2020 - 2023, USD Million
  • TABLE 98 Nigeria Postpartum Depression Drugs Market by Route of Administration, 2024 - 2031, USD Million
  • TABLE 99 Nigeria Postpartum Depression Drugs Market by Distribution Channel, 2020 - 2023, USD Million
  • TABLE 100 Nigeria Postpartum Depression Drugs Market by Distribution Channel, 2024 - 2031, USD Million
  • TABLE 101 Nigeria Postpartum Depression Drugs Market by Type, 2020 - 2023, USD Million
  • TABLE 102 Nigeria Postpartum Depression Drugs Market by Type, 2024 - 2031, USD Million
  • TABLE 103 Rest of LAMEA Postpartum Depression Drugs Market, 2020 - 2023, USD Million
  • TABLE 104 Rest of LAMEA Postpartum Depression Drugs Market, 2024 - 2031, USD Million
  • TABLE 105 Rest of LAMEA Postpartum Depression Drugs Market by Treatment, 2020 - 2023, USD Million
  • TABLE 106 Rest of LAMEA Postpartum Depression Drugs Market by Treatment, 2024 - 2031, USD Million
  • TABLE 107 Rest of LAMEA Postpartum Depression Drugs Market by Route of Administration, 2020 - 2023, USD Million
  • TABLE 108 Rest of LAMEA Postpartum Depression Drugs Market by Route of Administration, 2024 - 2031, USD Million
  • TABLE 109 Rest of LAMEA Postpartum Depression Drugs Market by Distribution Channel, 2020 - 2023, USD Million
  • TABLE 110 Rest of LAMEA Postpartum Depression Drugs Market by Distribution Channel, 2024 - 2031, USD Million
  • TABLE 111 Rest of LAMEA Postpartum Depression Drugs Market by Type, 2020 - 2023, USD Million
  • TABLE 112 Rest of LAMEA Postpartum Depression Drugs Market by Type, 2024 - 2031, USD Million
  • TABLE 113 Key Information - Pfizer, Inc.
  • TABLE 114 Key Information - Eli Lilly And Company
  • TABLE 115 Key Information - Novartis AG
  • TABLE 116 Key Information - GlaxoSmithKline PLC
  • TABLE 117 Key Information - Merck & Co., Inc.
  • TABLE 118 Key Information - Biogen, Inc.
  • TABLE 119 Key Information - Teva Pharmaceuticals Industries Ltd.
  • TABLE 120 key information - Bausch Health Companies, Inc.
  • TABLE 121 Key Information - Cipla Limited
  • TABLE 122 Key Information - Sage Therapeutics, Inc.
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!